Interferon Regulatory Factors and Periodontal Disease
Interferon Regulatory Factors and Periodontal Disease
批准号:
8190148
负责人:
FRANK C GIBSON
金额:
$25.35万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2013-06-30
关键词:
AddressAnaerobic BacteriaAntigensAreaAttentionBacteriaBacterial InfectionsBiological AssayBone MarrowBone remodelingCellsChronicClinical DataDataDiseaseFutureGene ExpressionGenesGenetic TranscriptionGoalsHumanIRF3 geneImmune responseImmunoglobulin GIn VitroInfectionInflammationInflammatoryInflammatory ResponseInterferonsInterleukin-6InvestigationKnock-outKnockout MiceKnowledgeLifeLinkMeasuresMediatingMediator of activation proteinModelingMouth DiseasesMusNatural ImmunityOralOral cavityPathway interactionsPeriodontal DiseasesPorphyromonas gingivalisPositioning AttributeProductionProteinsRelative (related person)RoleSeveritiesSignal InductionSignal PathwaySignal TransductionT-LymphocyteTestingTissuesTooth LossTreatment ProtocolsTumor Necrosis Factor-alphaVirus DiseasesWorkbasebone losschemokinecytokinedefined contributionhuman IRF3 proteinin vivointerferon regulatory factor-3macrophagemouse modelnovelnovel strategiesoral infectionpathogenresearch studyresponsesoft tissuetranscription factor
中文摘要
描述(由申请人提供):由口腔中的一组细菌引起的炎症,如牙龈卟啉单胞菌(PG)是牙周病(PD)的一个关键方面。这种慢性炎症被认为会导致硬组织和软组织的破坏,在严重的疾病中会导致牙齿脱落。出乎意料的是,在人类PD组织中检测到了1型干扰素、干扰素-1以及干扰素诱导的蛋白激活正常T细胞表达和分泌调节蛋白(RANTES)的水平升高。这是意想不到的,因为1型干扰素是对病毒感染的先天免疫反应的一部分。这些干扰素在帕金森病中的作用基本上是未知的。干扰素调节因子(IRF)是产生1型干扰素的主要转录因子。这些转录因子还调节其他已知与炎症有关的基因的表达。IRF3和IRF7信号与宿主对牙周病原体的反应有关;然而,干扰素信号如何参与牙周病原体炎症的形成还不清楚。我们的初步数据证实,在PG培养的野生型巨噬细胞中,ifnb1基因的表达增加。此外,WT和IRF3-KO小鼠的巨噬细胞对活体PG的培养表明,IRF3在促炎细胞因子和趋化因子的产生中发挥了部分作用。在这里,我们提出了一套详细的相关研究,以开始描述宿主对牙周病原体反应的一个鲜为人知的领域,即IRF3信号的作用和PG引发的炎症建立。这些研究将为未来的扩大研究铺平道路,以确定在慢性炎症和口腔骨丢失的背景下IRF3信号的确切机制,这些标记与帕金森病相关。这项工作的最终目标是开始了解是否可以引导干预IRF3信号转导的策略来加强目前的帕金森病治疗方案。
公共卫生相关性:1型干扰素,如干扰素-1,是对病原性病毒感染的免疫反应的关键介质。新出现的数据表明,1型干扰素是作为宿主对细菌感染反应的一部分而产生的;然而,在牙周病的背景下,这一领域的研究非常不足。基于我们的初步数据,我们提出了一组有重点的研究,以1-定义牙周病原体牙龈卟啉单胞菌1型干扰素的产生和2-宿主1型干扰素的产生机制。
英文摘要
DESCRIPTION (provided by applicant): Inflammation elicited by a subset of bacteria that inhabit the oral cavity such as Porphyromonas gingivalis (Pg) is a key facet of periodontal disease (PD). This chronic inflammation is thought to drive the destruction of both hard and soft tissues that in severe disease leads to tooth loss. Unexpectedly, elevated levels of the type 1 interferon, interferon (IFN)-1, as well as the interferon-induced protein Regulated upon Activation Normal T cell Expressed and Secreted (RANTES) has been detected in human PD tissues. This is unexpected as type 1 interferons are part of the innate immune response to viral infection. The role of these interferons in PD is essentially unknown. Interferon regulatory factors (IRF) are the principal transcriptional factors used for production of type 1 interferons. These transcription factors also regulate expression of other groups of genes known to be involved in inflammation. IRF3 and IRF7 signaling have been implicated in host response to periodontal pathogens; however, it is unclear precisely how interferon signaling participates in the establishment of a nidus of inflammation to periodontal pathogens. Our preliminary data identify increased expression of the ifnb1 gene from wild type macrophages cultured with Pg. Furthermore, culture of live Pg with macrophages from WT and IRF3-KO mice demonstrate a partial role for IRF3 in pro-inflammatory cytokine and chemokine production. Here we propose a detailed set of related studies to begin to characterize a poorly understood area of host response to periodontal pathogens, namely the role of IRF3 signaling and with establishment of inflammation elicited by Pg. These studies will pave the way for future expanded investigations to define the precise mechanisms underlying IRF3 signaling in the context of chronic inflammation and oral bone loss, markers associated with PD. The ultimate goal of this work is to begin to understand whether strategies to intercede in IRF3-signaling can be channeled to augment current PD treatment regimens.
PUBLIC HEALTH RELEVANCE: Type 1 Interferons, such as interferon-1, are key mediators of the immune response to pathogenic virus infection. Emerging data indicate that type 1 interferons are produced as part of the host response to bacterial infections; however, this area is exceedingly understudied in the context of periodontal disease. Based on our preliminary data we propose a focused set of studies to 1- define production of and 2- mechanism underlying host type 1 interferon production to the periodontal pathogen Porphyromonas gingivalis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PPARs and periodontal disease
-
批准号:8968210
-
项目类别:
-
资助金额:$26.1万
-
财政年份:2015
-
负责人:FRANK C GIBSON
-
依托单位:
PPARs and periodontal disease
-
批准号:9309421
-
项目类别:
-
资助金额:$17.28万
-
财政年份:2015
-
负责人:FRANK C GIBSON
-
依托单位:
Oral Macrophage Function in the Context of Periodontal Disease and HIV Infection
-
批准号:8739537
-
项目类别:
-
资助金额:$62.14万
-
财政年份:2013
-
负责人:FRANK C GIBSON
-
依托单位:
Oral Macrophage Function in the Context of Periodontal Disease and HIV Infection
-
批准号:8730755
-
项目类别:
-
资助金额:$48.8万
-
财政年份:2013
-
负责人:FRANK C GIBSON
-
依托单位:
Interferon Regulatory Factors and Periodontal Disease
-
批准号:8287188
-
项目类别:
-
资助金额:$21.13万
-
财政年份:2011
-
负责人:FRANK C GIBSON
-
依托单位:
Innate Immunity, Lipid Signaling, and Chronic Infection
-
批准号:7790038
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2010
-
负责人:FRANK C GIBSON
-
依托单位:
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis
-
批准号:7781398
-
项目类别:
-
资助金额:$31.53万
-
财政年份:2007
-
负责人:FRANK C GIBSON
-
依托单位:
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis
-
批准号:8125507
-
项目类别:
-
资助金额:$5.91万
-
财政年份:2007
-
负责人:FRANK C GIBSON
-
依托单位:
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis
-
批准号:7278527
-
项目类别:
-
资助金额:$31.81万
-
财政年份:2007
-
负责人:FRANK C GIBSON
-
依托单位:
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis
-
批准号:7383108
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2007
-
负责人:FRANK C GIBSON
-
依托单位:
IInfection-Elicited Oral Bone Loss: TLR2, Ontogency, and Porphromonas Gingivalis
-
批准号:7579128
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2007
-
负责人:FRANK C GIBSON
-
依托单位:
P. gingivalis Capsule in Cell Inflammation
-
批准号:6613063
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2003
-
负责人:FRANK C GIBSON
-
依托单位:
The Role of p. gingivalis Capsule in Cell Inflammation
-
批准号:6846639
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2003
-
负责人:FRANK C GIBSON
-
依托单位:
P. gingivalis Capsule in Cell Inflammation
-
批准号:7169840
-
项目类别:
-
资助金额:$22.9万
-
财政年份:2003
-
负责人:FRANK C GIBSON
-
依托单位:
The Role of p. gingivalis Capsule in Cell Inflammation
-
批准号:6740925
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2003
-
负责人:FRANK C GIBSON
-
依托单位:
The Role of p. gingivalis Capsule in Cell Inflammation
-
批准号:7010327
-
项目类别:
-
资助金额:$23.58万
-
财政年份:2003
-
负责人:FRANK C GIBSON
-
依托单位:
ORAL IMMUNIZATION WITH GINGIPAIN DELIVERED BY SALMONELLA
-
批准号:6350576
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2001
-
负责人:FRANK C GIBSON
-
依托单位:
ORAL IMMUNIZATION WITH GINGIPAIN DELIVERED BY SALMONELLA
-
批准号:6070128
-
项目类别:
-
资助金额:$4.26万
-
财政年份:2000
-
负责人:FRANK C GIBSON
-
依托单位:
Innate Immunity, Lipid Signaling, and Chronic Infection
-
批准号:8527673
-
项目类别:
-
资助金额:$22.87万
-
财政年份:--
-
负责人:FRANK C GIBSON
-
依托单位:
Innate Immunity, Lipid Signaling, and Chronic Infection
-
批准号:8380357
-
项目类别:
-
资助金额:$29.39万
-
财政年份:--
-
负责人:FRANK C GIBSON
-
依托单位:
海外基金